Omar Khalil is a Managing Director at Santé Ventures who took the unusual path of leaving venture capital to hold senior commercial leadership roles at Baxter, Baxalta, and Kaléo before returning as an investor, giving him direct experience scaling products from early clinical stages to multi-billion-dollar commercial franchises. He leads Santé's Boston office as a biotech specialist who brings a commercial strategy and market access perspective to early-stage companies, emphasizing understanding of payer realities and end-market dynamics even at the company formation stage.